Oncimmune LLC has introduced a blood test for early detection of lung cancer…The test, EarlyCDT-Lung, is performed exclusively at the United Kingdom-based company’s De Soto laboratory, which uses high-precision, liquid-handling robots and other instruments to produce an accurate test result, the company said in a Tuesday release. The lab is registered through the Clinical Laboratory Improvement Amendments of 1988, enacted by Congress to ensure that U.S. laboratories meet standards for accuracy, reliability and timeliness.